Nomogram to Predict Good Neoangiogenesis After Indirect Revascularization Surgery in Patients with Moyamoya Disease: a Case–control Study
Kexin Yuan(Hebei General Hospital), Yahui Zhao(China Railway Corporation), Yuanli Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yunfan Zhou(Capital Medical University), Haibin Zhang(Capital Medical University), Qian Zhang(Brigham and Women's Hospital), Yan Zhang(Shenzhen Children's Hospital), Qiang Hao(Liaoning Normal University), Rong Wang(Capital Medical University), Xingju Liu(Capital Medical University), Ke Wang(Pennsylvania State University), Xun Ye(Capital Medical University)
Cited by 5
Related Papers
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
|Signal Transduction and Targeted Therapy|2020|1.2k
Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy
|Theranostics|2021|229
Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma
|ACS Nano|2023|116
Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease
|Journal of neurosurgery|2018|105
RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance
|Journal of neurosurgery|2016|88